CTRP9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects against Ischemic Heart Injury via Multiple Novel Signaling Pathways

BACKGROUND: Cell therapy remains the most promising approach against ischemic heart injury. However, the poor survival of engrafted stem cells in the ischemic environment limits their therapeutic efficacy for cardiac repair post myocardial infarction (MI). C1q/tumor necrosis factor–related protein-9...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circulation
Autors principals: Yan, Wenjun, Guo, Yongzhen, Tao, Ling, Lau, Wayne Bond, Gan, Lu, Yan, Zheyi, Guo, Rui, Gao, Erhe, Wong, G. William, Koch, Walter L., Wang, Yajing, Ma, Xin-Liang
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705403/
https://ncbi.nlm.nih.gov/pubmed/28978553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.117.029557
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars